Highest-materiality recent filing
Petco beats profitability goals in FY2025; reduces leverage to 3.0x; provides FY2026 outlook
Q4 net sales $1.5B (-2.4% YoY); comps -1.6%; Adjusted EBITDA $106.3M (+10.6%), above outlook.
Petco refi with $900M term loan and $600M 8.25% senior secured notes due 2031
$900M refinancing term loans at Term Benchmark + 4.25% (0% floor), maturing Feb 2031 with 1% annual amortization.
Petco completes debt refinancing; Glenn Murphy transitions to Chairman of Board
Debt refinancing closed Feb 2; previously announced; aims to reduce leverage and increase financial flexibility.
Petco prices $600M 8.25% senior secured notes due 2031 to refinance term loan
$600M aggregate principal of 8.250% senior secured notes due February 1, 2031.
Petco announces $650M senior secured notes offering due 2031 to refinance term loan
$650M aggregate principal of senior secured notes due 2031; guaranteed by Petco's subsidiary guarantors.
Petco launches $1.5B debt refinancing, reaffirms FY2025 outlook
Intends to refinance $1.5 billion of its current term loan to extend maturities; subject to market conditions.
Net sales $1.5B, down 3.1% YoY; comparable sales down 2.2% YoY.
Petco Q2 net sales down 2.3% YoY, EBITDA up; raises FY2025 earnings outlook
Q2 net sales $1.5B (-2.3% YoY); comparable sales -1.4%; gross margin expanded 120bps to 39.3%.
Petco Q1 net sales down 2.3% to $1.5B; net loss improves to $11.7M; reaffirms FY2025 outlook
Net sales $1.5B, down 2.3% YoY; comparable sales -1.3%; gross margin +30bps to 38.2%.
On May 19, 2025, Christy Lake resigned from the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) and its compensation committee, effective as of the election of directors at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
Max materiality 0.80 · Median 0.68 · Most common event earnings